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ABSTRAK
Neurotoksin Clostridium botulinum (BoNTs) merupakan salah satu penyebab kerugian ekonomi 
bagi industri peternakan. Kerugian ini dapat sebagai akibat langsung ketika ternak keracunan BoNTs 
atau secara tidak langsung ketika produk asal ternak terkontaminasi BoNTs sehingga produk tersebut 
dilarang untuk dipasarkan.  Untuk itu perlu dilakukan pengontrolan rutin penyebaran  BoNTs di 
lingkungan peternakan dan industri hasil ternak. Salah satu caranya adalah dengan melakukan deteksi 
rutin terhadap keberadaan BoNTs. Salah satu metode deteksi yang relatif cepat dan akurat adalah metode 
enzyme linkage immunosorbant assay (ELISA). Pada penelitian ini dilaporkan hasil pengembangan 
ELISA, menggunakan antibodi poliklonal produk lokal terhadap BoNTs-B. Antibodi dihasilkan dari 
enam mencit Balb/c dengan metode imunologi standar. Mencit diimunisasi 3 kali selama 8 minggu 
dengan toksoid C. Botulinum tipe B komersial dengan dosis 100 ng per ekor per injeksi. Antibodi yang 
dihasilkan dimurnikan dengan kombinasi metode presipitasi ammonium sulfat 50% (w/v) dan kolom 
protein A. Hasil studi pendahuluan ini menunjukkan bahwa metode ELISA yang dikembangkan mampu 
mendeteksi toksin Clostridium botulinum tipe B hingga 1,0 ng/ml.
Kata kunci: toksin C. botulinum, ELISA, antibodi poliklonal
ABSTRACT
Clostridium botulinum neurotoxin (BoNTs) is one of the causes of economic loss in the livestock 
industry. This economic loss would be as a direct result when animals poisoned by BoNTs or indirectly 
when the livestock products are contaminated by BoNTs, which end up with the products are banned by 
authority. Therefore a routine surveillance of BoNTs in the farm and in livestock product processing 
industry is urgently needed. One of the most relatively quick and accurate methods to perform a routine 
detection of the presence of BoNTs is enzyme-linkage immunosorbant assay (ELISA). In this article we 
describe the results of the development of ELISA, using polyclonal antibodies against BoNTs-B 
produced locally. Antibodies were generated from six Balb/c mice with standard immunological 
methods. Mice were immunized three times for a period of 8 weeks with a commercial type B 
Clostridium botulinum toxoid at a dose of 100 ng per mouse per injection. The resulting antibody was 
purified by a combination of ammonium sulfate precipitation 50% (w/v) technique and a protein A 
column method. The results of this preliminary study indicated that the developed ELISA method 
capable of detecting type B Clostridium botulinum toxin up to 1.0 ng/ml.
Keywords: C. botulinum toxin, ELISA, polyclonal antibody.
INTRODUCTION
Clostridium botulinum  neurotoxin (BoNTs) 
is the causative agent of botulism, a fatal disease 
characterized by muscular paralysis, which affect 
mammals, birds, and fish (Keto-Timonen et al., 
2005, Steinman et al., 2006). Livestock botulism 
is   a   worldwide   problem   that   causes   large 
economic losses (Steinman  et al., 2006).  The 
losses that incurred on the farm industry can be 
happened directly or indirectly. The direct loss 
occurred when the animal is attacked directly, 
such as when they ingest  C. botulinum  spores 
contaminated feed. Indirect losses arose if the 
spores are found in animal processed products 
such as sausages or burgers (Shapiro et al., 1998), 
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causes the products are no longer economically 
valuable   even   banned   by   the   authority.   To 
overcome   the   problems   early   prevention   is 
needed. This can be done by both routine handling 
of the livestock sanitary as well as maintaining the 
hygiene   of   processing   livestock   products.   In 
addition routine screening tests again BoNTs are 
required. 
Commonly test method performed is mouse 
bioassay, which measures the resistance of mice 
to the toxin (Witcome et al., 1999; Gessler et al., 
2005). The assay is able to detect up to one unit 
dose of one mouse lethal dose (1 MLD), which is 
equivalent   to   approximately   10   pg/ml   of 
neurotoxins (Sharma  et al., 2005). Hence, this 
method is categorized quite sensitive. However, 
the operational cost of this method is relatively 
high   due   to  the   need   of   mice   with  specific 
conditions. Furthermore it takes special skills, 
animal ethics concerns, as well as the specificity 
of neurotoxins detected is still very limited. It also 
needs quite long time to get results, which is 
about 4 days or more (Sharma  et al., 2005). 
Consequently   several   methods   have   been 
developed ranging from ELISA (Dezfulian et al., 
1984;   Witcome  et   al.,   1999),   immunoaffinity 
chromatographic   column   test   (Gessler  et   al., 
2005), fluorogenic assay (Anne et al., 2001), up to 
the bio-molecular test such as PCR (Fach et al., 
1995; Braconnier  et al., 2001; Kimura  et al., 
2001; Lindstrom et al., 2001; Fach et al., 2002). 
The advantages of the ELISA method are 
faster than the mouse bioassay method, sensitive 
with high specificity, easy to standardize, and is 
commonly performed even to the level of public 
health laboratories (Sotelo  et al., 2011).  In the 
present study it was attempted to develop an 
ELISA method to the C. botulinum toxin using the 
antibody which was developed locally. The results 
should  provide   a   better   understanding   of   the 
development of the method as well as to carry out 
an early protection against the spreading of  C. 
botulinum in the farm and animal industries.
MATERIALS AND METHODS
Polyclonal Antibody Production
Polyclonal antibodies used in this study were 
generating locally by Depamede and Kisworo 
(2009). Polyclonal antibodies were produced in 
mice based on Dixit et al., (2006) and Keller et 
al., (2008) with some modifications as mentioned 
by Depamede and Kisworo (2009). Six female 
Balb/c mice aged 6-8 weeks were immunized 
with a commercial type B  C. botulinum  toxoid 
(Lot No. B121908-01, Metabiologics, Inc., U.S). 
Mice were immunized 3 times for 8 weeks with a 
dose of 100 ng per mouse with 4 weeks interval. 
In the initial immunization, toxoid was mixed 
with complete Freund's adjuvant (CFA, Sigma) to 
form an emulsion. On the second immunization a 
mixture with incomplete Freund's adjuvant (ICFA, 
Sigma) was performed. The first and the second 
injection were carried out subcutaneously, while 
the third injection (at week 8) was administered 
intramuscularly. As a control, Balb/c mice were 
injected concurrently with the treatments but the 
toxoid  was  replaced  with  physiological  saline 
solution. Fourteen days after final immunization, 
serum of each treatment group and control was 
taken from the mouse tail. The serum was then 
frozen at -20°C until processed for purification. 
Isolation   and   Purification   of   Polyclonal 
Antibodies
Isolation   and   purification   of   polyclonal 
antibodies against BoNTs-B toxin generated from 
Balb/c   mice   was   carried   out   by   50%   (w/v) 
ammonium sulfate precipitation and Protein A 
column methods (Baumgarten, 1992). The purity 
of   the   antibody   was   analyzed   using   sodium 
dodecyl   sulfate   polyacrylamide   gel 
electrophoresis   (SDS-PAGE)   according   to 
Hempelmann (1992).
Development of ELISA 
The isolated antibodies and a commercial 
antibody (Abcam) were used to develop sandwich 
ELISA according to Farzamfar et al. (2007) with 
slight modification as performed by Depamede 
and Kisworo (2009). ELISA plates were firstly 
coated   with   rabbit   anti   type   B   (RaCB)  C. 
botulinum toxin commercial (Abcam) as the first 
antibody layer. Each well was coated with 100 µL 
(2 µg/ml) antibody in carbonate buffer solution 
pH 9.5 and then allowed to stand at 4°C for 12 
hours.  After   that   the   solution   was   discarded, 
replaced with 300 µL blocking solution (PBS 
containing 0.05% (v/v) Tween 20 (Sigma), and 
0.5% (w/v) bovine serum albumin) and allowed to 
stand for 60 minutes at room temperature. The 
plates were then washed five times with 300 
µL/well  of   washing   solution  (PBS   containing 
0.05% (v/v) Tween 20). After washing, the wells 
were   filled   with   50   µL/well   of   standard 
commercial   ELISA   for  C.   botulinum  toxin 
(Metabiologics, Inc.) with a concentration of 100 
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incubated for 60 min at room temperature. Then 
the plate was washed again 5 times and then 50 
µL of polyclonal antibody generated in this study 
as the second layer, concurrently with the controls 
was added in to the wells and incubated for 60 
minutes at room temperature. The purpose of 
these second  layer  antibodies  are as  a linker 
between   suspected   antigen   (BoNTs)   in   the 
samples   and   the   enzyme   Horseradish 
peroxidase(HRP)-conjugated   antibody.   After 
washing,   50   µL   goat-anti-mouse   IgG   HRP-
conjugated   antibodies   were   dropped   into   the 
ELISA  plate   wells   and   incubated   again   for 
another 60 minutes at room temperature. After the 
last wash, a 50 µL substrate was added to the 
wells and incubated for 5-10 minutes in the dark, 
at   room   temperature   until   the   reaction   color 
changes in the positive samples occurred. The 
reaction was stopped by adding 50 µL of 1 N 
H2SO4 then the reaction products were quantified 
by ELISA photo reader (DYNEX-MRX) on the 
optical density of 450 nm (OD 450). 
Data Analysis 
The   data   obtained   were   tabulated   and 
analyzed by a simple arithmetic mean (Mean ± 
SD) of the OD 450 (Drouet  et al.,  2003) and 
presented as reported by Depamede and Kisworo 
(2009). The calculation of  the limit  value of 
positive or negative test results (cut-off value, 
COV) is calculated based on Drouet et al.  (2003), 
ie, COV = average value of negative controls ± 3 
x SD of negative control value. Samples with a 
COV ≤ OD 450 value was designated negative, 
while   a   greater   than   COV   was   positive 
(Depamede and Kisworo, 2009).
RESULTS AND DISCUSSION
Of the six Balb/c mice used, one animal died 
during the study due to  unknown reasons, but 
certainly not as a result of vaccination. Of the 5 
mice leaved, 4 (80%) gave a positive immune 
response   or   produced   polyclonal   antibodies 
against type B  C. botulinum  toxin, and one of 
them gave a quite high immune response, while 
one was with the lowest immune response (+/-) as 
presented in Table 1.
From   these   results   it   appears   that   the 
immune response of Balb/c mice was individually 
quite   disperse   (variation   value   was   about 
47.63%), and only one mouse gave high enough 
immune response. These results were consistent 
with previous studies, especially when the vaccine 
or   immunogen   used   was   a   commercial 
immunogen; native immunogen reported to be 
more immunogenic than those of the commercial 
toxoid (Witcome et al., 1999; Keller, 2008). In the 
present study, immunogen used was a commercial 
C.   botulinum  toxoid.   Technically,   the   use   of 
commercial immunogen is more secure than the 
intact or native immunogen derived or isolated 
directly from C. botulinum. 
Furthermore, from the results of this study as 
reported also by Depamede and Kisworo (2009), 
it was noted also that the dose of 100 ng/ml gave 
a significant immune response (p<0.05) on the 
production of polyclonal antibodies (Figure 1). 
Polyclonal antibodies obtained were then purified 
by ammonium sulfate precipitation method and 
the protein A 'home made  mini-column'.  The 
results of purification were analyzed using SDS-
PAGE as shown in Figure 1. From this figure, it 
clear knwn that the antibody obtained was quite 
pure. 
Polyclonal antibody obtained was then used 
as a component of the development of indirect 
ELISA as mentioned in the mateials and methods 
or   as  explained  elsewhere   by  Depamede   and 
Kisworo   (2009).   Preliminary   results   of   the 
developed ELISA method in this study showed 
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Table 1.  Immune Response of Balb/c mice Against C. botulinum Toxoid
Balb/c Code
The mean value
OD450 (n=3)
Immune Response
(COV=0.350)
1 0.580 +
2 1.156 +++
3 †) †)
4 0.423 +/-
5 0.500 +
6 0.642 +
†) Mouse died during the study
(Source: Depamede and Kisworo, 2009).that polyclonal antibodies generated in this study 
can be used as a component of ingredients needed 
to develop immunoassay such as ELISA against 
C.  botulinum  toxin.  Figure  2   shows   that   the 
developed ELISA was able to detect type B C. 
botulinum  toxin up to a concentration of 1.0 
ng/ml.
When compared to the in vivo  mouse bio-
assay test, the results of this preliminary study 
were yet as sensitive as the bio-assay method. 
Bio-assay method was able to detect the toxin of 
C. botulinum from 0.01 up to 0.02 ng (Witcome et 
al., 1999). Although the bio-assay method is more 
sensitive, as mentioned elsewhere, the method 
requires animals with special handling, special 
skills, and time consume. Furthermore, there is a 
consideration of restrictions on the use of trial 
animals that increasingly constricted in the last 
few   decades   (Witcome  et   al.,  1999).   These 
considerations have led the researchers to develop 
a more practical method of testing by applying the 
principles of immunodiagnostics such as ELISA. 
Lee et al. (2005), Atassi (2006), and Keller 
(2008) suggested that if immunodiagnostics need 
to be  developed,  it would  be better  if  using 
antibodies produced from modified C.  botulinum-
intact   toxin.  They   found   that   "home-made 
vaccine" from native C. botulinum antigens were 
more  immunogenic   and   more   protective   than 
those   of   commercial   antigens   (Keller,   2008). 
Furthermore,  Witcome  et   al.  (1999)  has 
successfully developed  a modified ELISA  test 
using  monoclonal  antibodies  produced  from  the 
modified  native  C. botulinum  antigens.  It was 
claimed that the modified ELISA was able to 
detect the C. botulinum toxin up to 0.005 ng, or in 
other words two times more sensitive than the 
bio-assay method, which was able to detect 0.01 
ng (Witcome et al., 1999). From this account, it 
can  be  revealed  here  that  the  quality  of   the 
antibodies obtained in this preliminary study to be 
used as component for the development of ELISA 
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Figure 1.  Effects of a Commercial C.  botulinum Toxoid Vaccine Dosages on Production of Polyclonal 
Antibodies of Local Balb/c Mice (a) and a Representative Result of 12.5% SDS-PAGE Analysis of 
Polyclonal Antibodies (arrow) Purified by Protein A Column (b). 
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(a)   (b) can still be improved further. 
CONCLUSIONS 
An ELISA kit for detecting  C. botulinum 
toxins has been developed by applying polyclonal 
antibodies against C. botulinum generated locally 
in this preliminary study. 
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